Erbb-2 selective small molecule kinase inhibitors

Details Erbb-2 selective small molecule kinase inhibitors Erbb-2 selective small molecule kinase inhibitors

A - Human Necessities

61

K

A61K 31/277 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2417500

A novel method for erbB-2 kinase inhibition by compounds identified through computational modeling and data processing and/or rational and de novo drug design is provided. The compounds bind erbB-2 kinase molecules and can be used as erbB-2 kinase agonists or antagonists. These compounds are useful especially in the treatment of cancer, particularly breast cancer.

L'invention concerne un nouveau procédé d'inhibition de l'erB-2 kinase par des composés identifiés par modélisation computationnelle et traitement de base de données et/ou des composés avec conception de médicament rationnelle et de novo liant des molécules erbB-2 kinase, pouvant être utilisés comme agonistes ou antagoniste de erB-2 kinase. Ces composés sont utilisés principalement pour le traitement de cancers, en particulier, du cancer du sein.

Affiliated with

Also associated with

Rating

Erbb-2 selective small molecule kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erbb-2 selective small molecule kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erbb-2 selective small molecule kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1913983